Lipovir (Aciclovir)

Aciclovir is converted by viral enzymes into a triphosphate that blocks viral DNA polymerase, preventing viral DNA synthesis and halting replication of herpes simplex viruses at the site of application.

The dosing regimen for Lipovir is determined by the prescribing healthcare professional based on the infection’s location, severity, and patient factors. Patients should follow the specific instructions provided by their clinician.

Safety data for topical aciclovir in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lipovir.

To order Lipovir, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lipovir’s active ingredient, aciclovir, is a nucleoside analogue antiviral that directly inhibits viral DNA polymerase. Compared with non‑nucleoside topical agents, aciclovir offers a well‑established efficacy profile for herpes simplex lesions and is widely accepted as first‑line therapy.

Store Lipovir at ambient temperature, below 25 °C. Keep the tube tightly closed, in its original packaging, and protect it from moisture, direct sunlight and extreme temperatures to maintain product stability.

Apply a thin layer of Lipovir to the affected skin area, typically five times daily for the first few days, then reduce frequency as directed by a healthcare professional. Wash hands before and after application to avoid accidental contact with eyes or mucous membranes.

Serious risks, though rare, include allergic contact dermatitis, severe skin reactions such as Stevens‑Johnson syndrome, and systemic toxicity if applied over large body surfaces or on compromised skin. Immediate medical attention is required if these symptoms develop.

Lipovir should not be used by individuals with known hypersensitivity to aciclovir or any excipients in the formulation, and it is contraindicated on extensive broken skin or in patients with severe renal impairment without medical supervision.